DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Munster PN, Moore AP, Ismail-Khan R. et al.
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
J Clin Oncol 2012;
30: 533-538
We do not assume any responsibility for the contents of the web pages of other providers.